These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 19739694)
1. Antipsychotic drugs for first-episode schizophrenia: a comparative review. Salimi K; Jarskog LF; Lieberman JA CNS Drugs; 2009 Oct; 23(10):837-55. PubMed ID: 19739694 [TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
6. Amisulpride for schizophrenia. Mota NE; Lima MS; Soares BG Cochrane Database Syst Rev; 2002; 2002(2):CD001357. PubMed ID: 12076408 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Lieberman JA; Tollefson G; Tohen M; Green AI; Gur RE; Kahn R; McEvoy J; Perkins D; Sharma T; Zipursky R; Wei H; Hamer RM; Am J Psychiatry; 2003 Aug; 160(8):1396-404. PubMed ID: 12900300 [TBL] [Abstract][Full Text] [Related]
8. Olanzapine for schizophrenia. Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619 [TBL] [Abstract][Full Text] [Related]
9. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026 [TBL] [Abstract][Full Text] [Related]
10. Quetiapine : A Review of its Use in Schizophrenia. Gunasekara NS; Spencer CM CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016 [TBL] [Abstract][Full Text] [Related]
11. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design. Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374 [TBL] [Abstract][Full Text] [Related]
12. Olanzapine for schizophrenia. Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S Cochrane Database Syst Rev; 2003; (1):CD001359. PubMed ID: 12535408 [TBL] [Abstract][Full Text] [Related]
13. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Swainston Harrison T; Perry CM Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633 [TBL] [Abstract][Full Text] [Related]
14. Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials. Tuunainen A; Wahlbeck K; Gilbody S Schizophr Res; 2002 Jul; 56(1-2):1-10. PubMed ID: 12084413 [TBL] [Abstract][Full Text] [Related]
15. Newer atypical antipsychotic medication versus clozapine for schizophrenia. Tuunainen A; Wahlbeck K; Gilbody SM Cochrane Database Syst Rev; 2000; (2):CD000966. PubMed ID: 10796559 [TBL] [Abstract][Full Text] [Related]
16. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study. Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378 [TBL] [Abstract][Full Text] [Related]
17. Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability. Bishara D; Taylor D Drugs; 2008; 68(16):2269-92. PubMed ID: 18973393 [TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness in first-episode patients. Ohlsen RI; O'Toole MS; Purvis RG; Walters JT; Taylor TM; Jones HM; Pilowsky LS Eur Neuropsychopharmacol; 2004 Nov; 14 Suppl 4():S445-51. PubMed ID: 15572263 [TBL] [Abstract][Full Text] [Related]
19. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715 [TBL] [Abstract][Full Text] [Related]
20. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]